Form 4 Filing for Khoja Hamid

Khoja Hamid, Chief Scientific Officer of FibroBiologics, Inc., acquired 298,508 shares of common stock and accompanying warrants in a private placement on September 15, 2026. The combined purchase price for each share and warrant was $1.675. The warrants are exercisable until expiration. This filing also includes a Power of Attorney granted by Hamid Khoja to Ruben A. Garcia, Jason D. Davis, and Pete O’Heeron, authorizing them to act on his behalf for securities law filings.